market news: Biotech

all stories tagged «Biotech».

stories appear here with a 15-minute delay. in real time — via the api connect the api →

1 story

macro14 October 2026 at 10:13 UTC

HC Wainwright & Co. kept its Buy rating on Biomea Fusion with a $4.00 price target, citing OPAL study progress and Phase 1 data for BMF-650.

3 sources · Newsmetry API